Benefits of colorectal cancer screening using fecal immunochemical testing with varying positivity thresholds by age and sex.
Saved in:
| Title: | Benefits of colorectal cancer screening using fecal immunochemical testing with varying positivity thresholds by age and sex. |
|---|---|
| Authors: | Harlass M; Department of Public Health, Erasmus University Medical Center, Rotterdam, the Netherlands., Knudsen AB; Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA, United States.; Department of Radiology, Harvard Medical School, Boston, MA, United States., Nieboer D; Department of Public Health, Erasmus University Medical Center, Rotterdam, the Netherlands., van Duuren LA; Department of Public Health, Erasmus University Medical Center, Rotterdam, the Netherlands., Kuntz KM; Division of Health Policy and Management, School of Public Health, University of Minnesota, Minneapolis, MN, United States., Rutter CM; Biostatistics Program, Public Health Sciences Division, Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Center, Seattle, WA, United States., Nascimento de Lima P; Engineering and Applied Sciences Department, RAND Corporation, Arlington VA, United States., Collier N; Decision and Infrastructure Sciences, Argonne National Laboratory, Lemont, IL, United States.; Consortium for Advanced Science and Engineering, University of Chicago, Chicago, IL, United States., Ozik J; Decision and Infrastructure Sciences, Argonne National Laboratory, Lemont, IL, United States.; Consortium for Advanced Science and Engineering, University of Chicago, Chicago, IL, United States., Hahn AI; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, United States., Alarid-Escudero F; Department of Health Policy, School of Medicine, Stanford University, Stanford, CA, United States.; Stanford Health Policy, Freeman-Spogli Institute for International Studies, Stanford University, Stanford, CA, United States., Zauber AG; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, United States., Inadomi JM; Department of Internal Medicine, The Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, UT, United States., Meester RGS; Department of Public Health, Erasmus University Medical Center, Rotterdam, the Netherlands.; Health Economics and Outcomes Research, Freenome Holdings Inc, South San Francisco, CA, United States.; Division of Gastroenterology and Hepatology, School of Medicine, Stanford University, Stanford, CA, United States., Lansdorp-Vogelaar I; Department of Public Health, Erasmus University Medical Center, Rotterdam, the Netherlands. |
| Source: | Journal of the National Cancer Institute [J Natl Cancer Inst] 2025 Nov 01; Vol. 117 (11), pp. 2219-2228. |
| Publication Type: | Journal Article; Meta-Analysis |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40581741 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Benefits of colorectal cancer screening using fecal immunochemical testing with varying positivity thresholds by age and sex. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Harlass+M%22">Harlass M</searchLink>; Department of Public Health, Erasmus University Medical Center, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Knudsen+AB%22">Knudsen AB</searchLink>; Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA, United States.; Department of Radiology, Harvard Medical School, Boston, MA, United States.<br /><searchLink fieldCode="AU" term="%22Nieboer+D%22">Nieboer D</searchLink>; Department of Public Health, Erasmus University Medical Center, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Duuren+LA%22">van Duuren LA</searchLink>; Department of Public Health, Erasmus University Medical Center, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Kuntz+KM%22">Kuntz KM</searchLink>; Division of Health Policy and Management, School of Public Health, University of Minnesota, Minneapolis, MN, United States.<br /><searchLink fieldCode="AU" term="%22Rutter+CM%22">Rutter CM</searchLink>; Biostatistics Program, Public Health Sciences Division, Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Center, Seattle, WA, United States.<br /><searchLink fieldCode="AU" term="%22Nascimento+de+Lima+P%22">Nascimento de Lima P</searchLink>; Engineering and Applied Sciences Department, RAND Corporation, Arlington VA, United States.<br /><searchLink fieldCode="AU" term="%22Collier+N%22">Collier N</searchLink>; Decision and Infrastructure Sciences, Argonne National Laboratory, Lemont, IL, United States.; Consortium for Advanced Science and Engineering, University of Chicago, Chicago, IL, United States.<br /><searchLink fieldCode="AU" term="%22Ozik+J%22">Ozik J</searchLink>; Decision and Infrastructure Sciences, Argonne National Laboratory, Lemont, IL, United States.; Consortium for Advanced Science and Engineering, University of Chicago, Chicago, IL, United States.<br /><searchLink fieldCode="AU" term="%22Hahn+AI%22">Hahn AI</searchLink>; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, United States.<br /><searchLink fieldCode="AU" term="%22Alarid-Escudero+F%22">Alarid-Escudero F</searchLink>; Department of Health Policy, School of Medicine, Stanford University, Stanford, CA, United States.; Stanford Health Policy, Freeman-Spogli Institute for International Studies, Stanford University, Stanford, CA, United States.<br /><searchLink fieldCode="AU" term="%22Zauber+AG%22">Zauber AG</searchLink>; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, United States.<br /><searchLink fieldCode="AU" term="%22Inadomi+JM%22">Inadomi JM</searchLink>; Department of Internal Medicine, The Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, UT, United States.<br /><searchLink fieldCode="AU" term="%22Meester+RGS%22">Meester RGS</searchLink>; Department of Public Health, Erasmus University Medical Center, Rotterdam, the Netherlands.; Health Economics and Outcomes Research, Freenome Holdings Inc, South San Francisco, CA, United States.; Division of Gastroenterology and Hepatology, School of Medicine, Stanford University, Stanford, CA, United States.<br /><searchLink fieldCode="AU" term="%22Lansdorp-Vogelaar+I%22">Lansdorp-Vogelaar I</searchLink>; Department of Public Health, Erasmus University Medical Center, Rotterdam, the Netherlands. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227503089%22">Journal of the National Cancer Institute</searchLink> [J Natl Cancer Inst] 2025 Nov 01; Vol. 117 (11), pp. 2219-2228. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Meta-Analysis – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7503089 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1460-2105 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200278874%22">00278874 </searchLink><i>NLM ISO Abbreviation: </i>J Natl Cancer Inst <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40581741 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/jnci/djaf149 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2219 Titles: – TitleFull: Benefits of colorectal cancer screening using fecal immunochemical testing with varying positivity thresholds by age and sex. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Harlass M – PersonEntity: Name: NameFull: Knudsen AB – PersonEntity: Name: NameFull: Nieboer D – PersonEntity: Name: NameFull: van Duuren LA – PersonEntity: Name: NameFull: Kuntz KM – PersonEntity: Name: NameFull: Rutter CM – PersonEntity: Name: NameFull: Nascimento de Lima P – PersonEntity: Name: NameFull: Collier N – PersonEntity: Name: NameFull: Ozik J – PersonEntity: Name: NameFull: Hahn AI – PersonEntity: Name: NameFull: Alarid-Escudero F – PersonEntity: Name: NameFull: Zauber AG – PersonEntity: Name: NameFull: Inadomi JM – PersonEntity: Name: NameFull: Meester RGS – PersonEntity: Name: NameFull: Lansdorp-Vogelaar I IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: 2025 Nov 01 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1460-2105 Numbering: – Type: volume Value: 117 – Type: issue Value: 11 Titles: – TitleFull: Journal of the National Cancer Institute Type: main |
| ResultId | 1 |